| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(89)90866-0 |
| P698 | PubMed publication ID | 2551505 |
| P2093 | author name string | Martin P | |
| Schiller JT | |||
| Lowy DR | |||
| Vass WC | |||
| Velu TJ | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 21-32 | |
| P577 | publication date | 1989-10-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors | |
| P478 | volume | 59 |
| Q36656196 | A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase |
| Q74638043 | A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments |
| Q33816914 | A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability |
| Q30450210 | A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma |
| Q39595937 | Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication |
| Q41080345 | Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein |
| Q33603447 | Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element |
| Q36654255 | Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation |
| Q36709293 | Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor |
| Q40860423 | Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation |
| Q36797809 | Biological properties of the deer papillomavirus E5 gene in mouse C127 cells: growth transformation, induction of DNA synthesis, and activation of the platelet-derived growth factor receptor |
| Q34291548 | Biology of human papillomaviruses |
| Q44490670 | Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases |
| Q36700658 | Bovine papillomavirus type 1 alters the processing of host glucose- and calcium-modulated endoplasmic reticulum proteins |
| Q36756472 | Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the neuroretina |
| Q42662548 | Characterization of the mouse beta-prime adaptin gene; cDNA sequence, genomic structure, and chromosomal localization |
| Q33835105 | Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins |
| Q40755894 | Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins |
| Q35011943 | During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element |
| Q37619573 | E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells |
| Q35858985 | E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation |
| Q36315104 | ERK- and JNK-dependent signaling pathways contribute to Bombyx mori nucleopolyhedrovirus infection |
| Q36684327 | Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long c |
| Q35831275 | Epidermal growth factor receptors in idiopathic and virally induced skin diseases |
| Q43248887 | ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease |
| Q35830353 | Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells |
| Q67699937 | Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues |
| Q42803602 | Expression of the bovine papillomavirus type 1 E5B gene reveals a protein-protein interaction of the E5A and E5B gene products |
| Q41820272 | Golgi alkalinization by the papillomavirus E5 oncoprotein |
| Q24336345 | HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers |
| Q42756293 | Heparin alters epidermal growth factor metabolism in cultured rat glomerular epithelial cells |
| Q42806519 | Heterogeneity in epidermal growth factor responsiveness and tumor growth of human maxillary cancer cell lines |
| Q40675122 | How DNA viruses perturb functional MHC expression to alter immune recognition. |
| Q36406751 | Human papillomavirus type 16 E5 protein as a therapeutic target |
| Q35196630 | Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation |
| Q35895171 | Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein |
| Q41699789 | Immunodetection of the Ligand-Activated Receptor for Epidermal Growth Factor |
| Q39577267 | Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. |
| Q36550896 | Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling |
| Q37071223 | Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue |
| Q33183198 | Mechanisms of cell transformation by papillomavirus E5 proteins |
| Q41650748 | Molecular cloning, analysis, and chromosomal localization of a mouse genomic sequence related to the human papillomavirus type 18 E5 region |
| Q40701066 | Molecular examination of the transmembrane requirements of the platelet-derived growth factor beta receptor for a productive interaction with the bovine papillomavirus E5 oncoprotein |
| Q28776617 | Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind |
| Q35000599 | Multiple transmembrane amino acid requirements suggest a highly specific interaction between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor beta receptor |
| Q35849030 | Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. |
| Q35846414 | Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells. |
| Q40638007 | Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. |
| Q36690316 | Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein |
| Q30453944 | Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers |
| Q37099438 | Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions |
| Q33849552 | Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun |
| Q41639700 | Retention of epidermal growth factor receptors in the endoplasmic reticulum of adenovirus-infected cells |
| Q36729738 | Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor |
| Q24656940 | Role of Zn2+ ions in host-virus interactions |
| Q37241876 | Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree |
| Q35228909 | Signal Transduction by the Colony-Stimulating Factor-1 Receptor; Comparison to Other Receptor Tyrosine Kinases |
| Q38370778 | Signaling pathways in HPV-associated cancers and therapeutic implications. |
| Q36634049 | Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells |
| Q37119249 | Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells |
| Q34134605 | Structural role of the conserved cysteines in the dimerization of the viral transmembrane oncoprotein E5. |
| Q36233063 | Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses |
| Q40245388 | Suprabasal overexpression of beta-1 integrin is induced by bovine papillomavirus type 1. |
| Q36694749 | The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor |
| Q24337640 | The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions |
| Q36685093 | The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and phosphatidylinositol-3'-kinase in NIH 3T3 cells |
| Q33916978 | The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein |
| Q36650838 | The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes |
| Q36715662 | The E5 oncoprotein target: A 16-kDa channel-forming protein with diverse functions |
| Q33763373 | The EGFR as a target for viral oncoproteins. |
| Q82858263 | The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating |
| Q35841701 | The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. |
| Q36743425 | The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH. |
| Q37319770 | The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango |
| Q33292296 | The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. |
| Q39877479 | The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts |
| Q36656359 | The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many hydrophobic amino acid sequences containing a glutamine |
| Q36824208 | The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an alpha-adaptin-like molecule: a possible link between growth factor receptors and viral transformation |
| Q36820980 | The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription |
| Q41301893 | The genetic program of genital human papillomaviruses in infection and cancer |
| Q36638250 | The genomes of the animal papillomaviruses European elk papillomavirus, deer papillomavirus, and reindeer papillomavirus contain a novel transforming gene (E9) near the early polyadenylation site |
| Q36655687 | The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. |
| Q42829683 | The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1). |
| Q36653794 | The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein |
| Q33180948 | The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein |
| Q40281053 | The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits |
| Q42817465 | The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces |
| Q36651868 | Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain |
| Q36809556 | Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells |
| Q36829187 | Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16 |
| Q42603771 | Tyrphostin AG 555 inhibits bovine papillomavirus transcription by changing the ratio between E2 transactivator/repressor function |
| Q40654172 | Upregulation of Swelling‐Activated Cl− Channel Sensitivity to Cell Volume by Activation of EGF Receptors in Murine Mammary Cells |
| Q28115609 | Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein |
| Q41374895 | Virocrine transformation |
| Q42518739 | c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation |
Search more.